Publications

Publications

At Bayer, we are working in collaboration with the leading scientific, academic, and community partners to improve our understanding of cardiorenal diseases.  

 

We invite you to explore Bayer-supported publications pertaining to chronic kidney disease associated with type 2 diabetes. This library is not intended to serve as a comprehensive repository of all publications. Publications not supported by Bayer are not included. Access to the full text of publications may depend on journal access rights.

 

To help narrow down your search, choose the relevant tags and click apply. Applying multiple tags will narrow your results.

 

Last updated: August 28, 2026

Types of Enhancements Available

audio
Audio
infographic
Graphical Abstract
PLS
Plain Language Summary
video
Video
other
Others

To help narrow down your search, select the relevant filters from the dropdowns and Click Apply

Hold down Ctrl key on keyboard to select multiple years

Total available publications: 287    

Filtered results: 287

Cardio-Renal Protection of MRAs in Kidney-Transplanted Diabetic Patients

El Essawy B, et al., SD. 2026

Basset El Essawy, 27 10 2026

Combination Pharmacotherapy in Type 2 Diabetes and Chronic Kidney Disease: Translating Evidence into Clinical Practice

Lovshin J, NDT. 2026

Julie A. Lovshin, 20 10 2026

Effects of Renin–Angiotensin Inhibitors, Sodium–Glucose Cotransporter 2 Inhibitors, Mineralocorticoid Receptor Antagonists and Glucagon-Like Peptide 1 Receptor Agonists on Kidney Outcomes in Patients With T1D: A Systematic Review and Meta-Analysis

Perry F, et al., DOM. 2026

Frances Perry, 20 10 2026

Practical Implementation of Steroidal and Nonsteroidal Mineralocorticoid Receptor Antagonists in the Management of Heart Failure

Michos E, SD. 2026

Erin D. Michos, 20 10 2026

Undiagnosed Chronic Kidney Disease, Outcomes, and Finerenone in Heart Failure: The FINEARTS-HF Randomized Clinical Trial

Ostrominski J, et al., JAMA Card. 2026

John W. Ostrominski , 22 09 2026

HFpEF-ABA Score and Finerenone in Patients With Heart Failure and Mildly Reduced or Preserved Ejection Fraction: Insights From the FINEARTS-HF Trial

Ono R, et al., JACC HF. 2026

Ryohei Ono, 16 09 2026

Acute eGFR Changes With Finerenone Examined in a Prespecified Analysis of FINE-ONE

Cherney D, et al, KIR. 2026

David Z.I. Cherney, 15 09 2026

Effectiveness of Finerenone in Slowing Chronic Kidney Disease Progression After Hospitalization for Heart Failure: A FIDELITY Subgroup Analysis

Shafi T, et al, EJHF. 2026

Tariq Shafi, 15 09 2026

The HFpEF-ABA Score, Incident Heart Failure, and Finerenone in Chronic Kidney Disease with Type 2 Diabetes

Inciardi RM., et al, JOCF. 2026

Inciardi, R, 31 08 2026

Finerenone in Hypertensive Non-Diabetic Chronic Kidney Disease: A FIND-CKD Subgroup Analysis

Heerspink H, et al., EHJ. 2026

Hiddo J.L. Heerspink, 27 08 2026